1. Haematological Malignancy Research Network [Internet]. HMRN. 2022 [cited 2022 Jun 13]. Available from: https://www.hmrn.org/statistics/incidence
2. The chronic myeloid leukaemia story in the United Kingdom since 1960;Clark RE;British Journal of Haematology,2020
3. Baccarani M, Pane F. A Critical History of Chromic Myeloid Leukemia. Mediterr J Hematol Infect Dis [Internet]. 2014 Jan 2 [cited 2021 Mar 3];6(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894841/
4. Williams LA, Garcia Gonzalez AG, Ault P, Mendoza TR, Sailors ML, Williams JL, et al. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 1;122(5):641–7.
5. Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population;Efficace F;Blood. 2011 Oct